HER2 Nanoparticle Safety and Specificity Data Presented at AACR 2019

Marie Zhang, PhD, Vice President of Research and Clinical Development at Imagion Biosystems, presented the poster "HER2 Functionalized Nanoparticles Are Safe…


MagSense® Pre-Clinical Safety Data from AACR 2018

Pre-clinical data on Imagion Biosystems' MagSense HER2+ cancer detection platform have shown: specific binding and detection of HER2+ tumor cells in vitro…


Audio Recording of December 2017 Investor Update Call — Listen Here

The audio file of the December 2017 Investor Update call is now available. Listen here:…